Signalway Antibody
Suzhou, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
A specialist producer of research antibodies and kits, particularly for challenging targets like post-translational modifications.
Technology Platform
Specializes in generating antibodies against post-translational modifications and conformational epitopes using proprietary immunization and screening protocols.
Opportunities
High demand for well-validated research tools in growing fields like immuno-oncology and epigenetics drives growth.
Risk Factors
Business is highly dependent on the academic research budget cycle and faces constant technological disruption from new detection methods.
Competitive Landscape
Occupies a specialized niche but competes with the broad catalogs of larger reagent companies and other niche antibody suppliers.